Infectious Diseases in Critical Care Medicine

71. Fraser TG, Zembower TR, Lynch P, et al. CavitaryLegionellapneumonia in a liver transplant
    recipient. Transpl Infect Dis 2004; 6(2):77–80.


72. Singh N, Gayowski T, Wagener M, et al. Pulmonary infections in liver transplant recipients receiving
    tacrolimus. Changing pattern of microbial etiologies. Transplantation 1996; 61(3):396–401.


73. Nichols L, Strollo DC, Kusne S. Legionellosis in a lung transplant recipient obscured by
    cytomegalovirus infection andClostridium difficilecolitis. Transpl Infect Dis 2002; 4(1):41–45.


74. Horbach I, Fehrenbach FJ. Legionellosis in heart transplant recipients. Infection 1990; 18(6):361–363.


75. Mattner F, Kola A, Fischer S, et al. Impact of bacterial and fungal donor organ contamination in lung,
    heart-lung, heart and liver transplantation. Infection 2008; 36(3):207–212.


76. Ampel NM, Wing EJ.Legionellainfection in transplant patients. Semin Respir Infect 1990;5(1):30–37.


77. Miller R, Burton NA, Karwande SV, et al. Early, aggressive open lung biopsy in heart transplant
    recipients. J Heart Transplant 1987; 6(2):96–99.


78. Dowling JN, Pasculle AW, Frola FN, et al. Infections caused byLegionella micdadeiandLegionella
    pneumophilaamong renal transplant recipients. J Infect Dis 1984; 149(5):703–713.


79. Singh N, Muder RR, Yu VL, et al.Legionellainfection in liver transplant recipients: implications for
    management. Transplantation 1993; 56(6):1549–1551.


80. Ogunc G, Ozdemir T, Vural T, et al. [Legionnaires’ disease following kidney transplantation].
    Mikrobiyol Bul 1993; 27(2):137–142.


81. La Scola B, Michel G, Raoult D. Isolation ofLegionella pneumophilaby centrifugation of shell vial cell
    cultures from multiple liver and lung abscesses. J Clin Microbiol 1999; 37(3):785–787.


82. Chaberny IF, Ziesing S, Gastmeier P. [Legionellaprevention in intensive care units]. Anasthesiol
    Intensivmed Notfallmed Schmerzther 2004; 39(3):127–131.


83. Vonberg RP, Eckmanns T, Bruderek J, et al. Use of terminal tap water filter systems for prevention of
    nosocomial legionellosis. J Hosp Infect 2005; 60(2):159–162.


84. Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997;
    10(1):86–124.


85. Mun ̃oz P, Rodriguez C, Bouza E.Mycobacterium tuberculosisinfection in recipients of solid organ
    transplants. Clin Infect Dis 2005; 40(4):581–587.


86. Mun ̃oz P, Palomo J, Mun ̃oz R, et al. Tuberculosis in heart transplant recipients. Clin Infect Dis 1995;
    21:398–402.


87. Paterson DL, Singh N, Gayowski T, et al. Pulmonary nodules in liver transplant recipients. Medicine
    1998; 77(1):50–58.


88. Aguado JM, Herrero JA, Gavalda J, et al. Clinical presentation and outcome of tuberculosis in
    kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study
    Group, GESITRA.Transplantation 1997; 63(9):1278–1286.


89. Mun ̃oz P, Burillo A, Palomo J, et al.Rhodococcus equiinfection in transplant recipients: case report
    and review of the literature. Transplantation 1997; 65:449–453.


90. Wiesmayr S, Stelzmueller I, Tabarelli W, et al. Nocardiosis following solid organ transplantation: a
    single-centre experience. Transpl Int 2005; 18(9):1048–1053.


91. Vigano SM, Edefonti A, Ferraresso M, et al. Successful medical treatment of multiple brain abscesses
    due toNocardia farcinica in a paediatric renal transplant recipient. Pediatr Nephrol 2005;
    20(8):1186–1188.


92. Queipo-Zaragoza JA, Broseta-Rico E, Alapont-Alacreu JM, et al. Nocardial infection in immunosup-
    pressed kidney transplant recipients. Scand J Urol Nephrol 2004; 38(2):168–173.


93. Kahraman S, Genctoy G, Arici M, et al. Septic arthritis caused byNocardia asteroidesin a renal
    transplant recipient. Transplant Proc 2004; 36(5):1415–1418.


94. Nouza M, Prat V. [Lung infection after kidney transplantation. I. Etiology, pathogenesis and clinical
    picture]. Cas Lek Cesk 1990; 129(21):641–644.


95. Poonyagariyagorn HK, Gershman A, Avery R, et al. Challenges in the diagnosis and management of
    Nocardiainfections in lung transplant recipients. Transpl Infect Dis 2008; 10(6):403–408.


96. Mun ̃oz P, Burillo A, Bouza E. Mold infection in solid organ transplant patients. In: Bowden RA,
    Ljungman P, Paya C, eds. Transplant Infections. 2nd ed. Lippincott Williams & Wilkins, 2003.


97. Gavalda`J, Len O, Rovira M, et al. Epidemiology of invasive fungal infections (IFI) in solid organ
    (SOT) and hematopoeitic stem cell (HSCT) transplant recipients: a prospective study from RESITRA.
    45th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2005, Washington (abstr
    M-990/461).


98. Dummer JS, Lazariashvilli N, Barnes J, et al. A survey of anti-fungal management in lung
    transplantation. J Heart Lung Transplant 2004; 23(12):1376–1381.


99. Monforte V, Roman A, Gavalda J, et al. Nebulized amphotericin B prophylaxis forAspergillus
    infection in lung transplantation: study of risk factors. J Heart Lung Transplant 2001; 20(12):
    1274–1281.

Infections in Organ Transplants in Critical Care 411